Morocco Archives - Page 2 of 2

2 January 2016

African Treatment Advocates Call on ViiV Healthcare to Unlock Access to Dolutegravir …

Algeria, Dolutegravir, HIV, Intellectual Proprety, Libya, Morocco, REGION, Tunisia 74 Views

Harare, December 1st, 2015 Today, at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates and activists from all over Africa united to urge ViiV Healthcare to allow affordable access to

26 June 2015

Launch of Moroccan Generic Sofosbuvir: A Victory for the Wide-spread Use HCV Treatmen…

ARV, Daclatasvir, HCV, Hepatitis, Intellectual Proprety, Morocco, North Africa, Sofosbuvir 109 Views

According to the Ministry of Health, 625,000 people are infected by HCV, 1.6% of the general population of Morocco. Of those infected, 267,000 people have active chronic infection requiring treatment. Until recently, the management

10 July 2014

The first Middle East and North Africa Community Advisory Board (MENA-CAB)

Advocacy, AIDS, Algeria, ARV, Daclatasvir, Dolutegravir, Guidelines, HIV, Intellectual Proprety, Libya, Middle East, Morocco, North Africa, REGION, Tunisia 81 Views

Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population, the

18 July 2012

GENERATION OF CHANGE: Portraits of HIV & AIDS Activists from MENA

Advocacy, AIDS, Algeria, HIV, Libya, Middle East, Morocco, News, REGION, Tunisia 75 Views

The Middle East/North Africa (MENA) region is in turmoil. The trajectory and consequences of the current political, social and economic transformations rippling across the region will become clear in the years ahead. Meanwhile, the